{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:06:01Z","timestamp":1784185561060,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jiac.2026.103015","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:45:40Z","timestamp":1781541940000},"page":"103015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetics of intravenous metronidazole in the plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients undergoing lower gastrointestinal surgery"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8209-7704","authenticated-orcid":false,"given":"Hiroyuki","family":"Taogoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ohge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuro","family":"Ikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinnosuke","family":"Uegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9069-463X","authenticated-orcid":false,"given":"Norifumi","family":"Shigemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Shimbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.103015_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jiac.2021.03.010","article-title":"Change in antimicrobial susceptibility of pathogens isolated from surgical site infections over the past decade in Japanese nation-wide surveillance study","volume":"27","author":"Ueda","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103015_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jiac.2018.02.011","article-title":"Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan","volume":"24","author":"Takesue","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103015_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jiac.2017.03.010","article-title":"Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: comparison of data from nationwide surveillance studies conducted in 2010 and 2014\u20132015","volume":"23","author":"Takesue","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103015_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jiac.2014.10.005","article-title":"Efficacy and safety of metronidazole injection for the treatment of infectious peritonitis, abdominal abscess and pelvic inflammatory diseases in Japan","volume":"21","author":"Mikamo","year":"2015","journal-title":"J Infect Chemother"},{"issue":"1","key":"10.1016\/j.jiac.2026.103015_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/sur.2013.9999","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"14","author":"Bratzler","year":"2013","journal-title":"Surg Infect"},{"key":"10.1016\/j.jiac.2026.103015_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/SLA.0b013e31826c4009","article-title":"Antibiotic choice is independently associated with risk of surgical site infection after colectomy: a population-based cohort study","volume":"257","author":"Hendren","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.jiac.2026.103015_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jamcollsurg.2013.07.003","article-title":"Choice of intravenous antibiotic prophylaxis for colorectal surgery does matter","volume":"217","author":"Deierhoi","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jiac.2026.103015_bib8","doi-asserted-by":"crossref","first-page":"187.e1","DOI":"10.1016\/j.ajog.2017.03.019","article-title":"Reducing surgical site infections after hysterectomy: metronidazole plus cefazolin compared with cephalosporin alone","volume":"217","author":"Till","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jiac.2026.103015_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/jpids\/piy040","article-title":"Pharmacokinetic and pharmacodynamic properties of metronidazole in pediatric patients with acute appendicitis: a prospective study","volume":"8","author":"Child","year":"2019","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.jiac.2026.103015_bib10","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/AAC.06012-11","article-title":"Therapeutic equivalence requires pharmaceutical, pharmacokinetic, and pharmacodynamic identities: true bioequivalence of a generic product of intravenous metronidazole","volume":"56","author":"Agudelo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103015_bib11","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1128\/AAC.48.11.4195-4199.2004","article-title":"Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron","volume":"48","author":"Ibrahim","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103015_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00558235","article-title":"Penetration of clindamycin and metronidazole into the appendix and peritoneal fluid in children","volume":"37","author":"Nagar","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2026.103015_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/AAC.34.2.376","article-title":"Penetration of clindamycin, cefoxitin, and metronidazole into pelvic peritoneal fluid of women undergoing diagnostic laparoscopy","volume":"34","author":"Berger","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103015_bib14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/00365528509088853","article-title":"Comparative pharmacokinetics of metronidazole and tinidazole and their tissue penetration","volume":"20","author":"Bergan","year":"1985","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jiac.2026.103015_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jac\/11.4.357","article-title":"Penetration of metronidazole to tissues","volume":"11","author":"Holter","year":"1983","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jiac.2026.103015_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5414\/CPP41267","article-title":"Pharmacokinetics and tissue penetration of pefloxacin plus metronidazole after administration as surgical prophylaxis in colorectal surgery","volume":"41","author":"Gasc\u00f3n","year":"2003","journal-title":"Int J Clin Pharm Ther"},{"key":"10.1016\/j.jiac.2026.103015_bib17","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1128\/AAC.35.12.2602","article-title":"Pharmacokinetics and tissue penetration of a single 1,000-milligram, intravenous dose of metronidazole for antibiotic prophylaxis of colorectal surgery","volume":"35","author":"Martin","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103015_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2022.100082","article-title":"Variability in the serum and tissue concentrations of pre-incisional ceftriaxone for surgery in paediatric population and outcome of surgical-site infections; an open labelled, prospective, non-randomized, analytical study","volume":"3","author":"Sheikh","year":"2022","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"10.1016\/j.jiac.2026.103015_bib19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijantimicag.2015.01.008","article-title":"Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: model-based evaluation of standard dosing regimens","volume":"45","author":"As\u00edn-Prieto","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2026.103015_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diagmicrobio.2006.06.013","article-title":"Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole","volume":"55","author":"Sprandel","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2026.103015_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2125.1995.tb05792.x","article-title":"Plasma hydroxy-metronidazole\/metronidazole ratio in patients with liver disease and in healthy volunteers","volume":"40","author":"Muscar\u00e1","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2026.103015_bib23","first-page":"1387","article-title":"Rapid measurement of metronidazole in sera and liver abscess fluid in the patients with amebiasis using HPLC","volume":"13","author":"Ohtomo","year":"1992","journal-title":"Ther Res"},{"issue":"2","key":"10.1016\/j.jiac.2026.103015_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jiac.2022.10.017","article-title":"Pharmacokinetics of flomoxef in plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients undergoing lower gastrointestinal surgery: dosing considerations based on site-specific pharmacodynamic target attainment","volume":"29","author":"Hirano","year":"2023","journal-title":"J Infect Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2026.103015_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jiac.2022.12.005","article-title":"Pharmacokinetics of cefmetazole in plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients scheduled for lower gastrointestinal surgery: dosing considerations based on site-specific pharmacodynamic target attainment","volume":"29","author":"Kaiki","year":"2023","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103015_bib26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A pharmacokinetic analysis program (MULTI) for microcomputer","volume":"4","author":"Yamaoka","year":"1981","journal-title":"J Pharmacobio-Dyn"},{"key":"10.1016\/j.jiac.2026.103015_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijantimicag.2013.08.016","article-title":"Application of pharmacokinetic\/pharmacodynamic modelling and simulation for the prediction of target attainment of ceftobiprole against meticillin-resistant Staphylococcus aureus using minimum inhibitory concentration and time-kill curve based approaches","volume":"43","author":"Barbour","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2026.103015_bib28","series-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria","year":"2018"},{"key":"10.1016\/j.jiac.2026.103015_bib29","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1093\/jac\/dkw247","article-title":"Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgery","volume":"71","author":"Zelenitsky","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2026.103015_bib30","first-page":"1","article-title":"The surgical infection society revised guidelines on the management of intra-abdominal infection","volume":"18","author":"Mazuski","year":"2017","journal-title":"Surg Infect Mary Ann Liebert Inc"},{"key":"10.1016\/j.jiac.2026.103015_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.amjsurg.2005.01.015","article-title":"Antimicrobial prophylaxis for surgery: an advisory statement from the National surgical infection prevention project","volume":"189","author":"Bratzler","year":"2005","journal-title":"Am J Surg"},{"key":"10.1016\/j.jiac.2026.103015_bib32","first-page":"549","article-title":"Antibioprophylaxis in surgery and interventional medicine (adult patients). Update 2017","volume":"38","author":"Martin","year":"2019","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.jiac.2026.103015_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1445-2197.2012.06244.x","article-title":"Single-dose antibiotic prophylaxis is effective enough in colorectal surgery","volume":"83","author":"Ahn","year":"2013","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.jiac.2026.103015_bib34","first-page":"e10","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America","volume":"59","author":"Stevens","year":"2014"},{"issue":"3","key":"10.1016\/j.jiac.2026.103015_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2024.102598","article-title":"Efficacy and safety of ceftazidime-avibactam in combination with metronidazole in Japanese patients with complicated intra-abdominal infection: a phase 3, multicentre, open-label study","volume":"31","author":"Mikamo","year":"2025","journal-title":"J Infect Chemother"},{"issue":"9","key":"10.1016\/j.jiac.2026.103015_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01904-24","article-title":"Clinical pharmacokinetics of metronidazole: a systematic review and meta-analysis","volume":"69","author":"Shahzad","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103015_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2125.1982.tb01962.x","article-title":"A comparison of the pharmacokinetics of metronidazole in man after oral administration of single doses of benzoylmetronidazole and metronidazole","volume":"14","author":"Houghton","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2026.103015_bib38","first-page":"231","article-title":"Pharmacokinetics of metronidazole in healthy adult volunteers after tablets and suppositories","volume":"26","author":"Bergan","year":"1980","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jiac.2026.103015_bib39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/AAC.19.5.754","article-title":"Liquid chromatographic assay for metronidazole and tinidazole: pharmacokinetic and metabolic studies in human subjects","volume":"19","author":"Nilsson-Ehle","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103015_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/AAC.22.1.165","article-title":"In vitro activity of the two principal oxidative metabolites of metronidazole against Bacteroides fragilis and related species","volume":"22","author":"Haller","year":"1982","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:33:18Z","timestamp":1784183598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26001133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1341321X26001133"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103015","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of intravenous metronidazole in the plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients undergoing lower gastrointestinal surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103015"}}